3878
J. Li et al. / Tetrahedron Letters 51 (2010) 3876–3878
chlorine gas and subsequent distillation.15 To avoid safety hazards
Cl
NH2
Cl
N
acrolein
with this route, an alternative to the Skraup synthesis was em-
ployed (Scheme 6). Regioselective nitration of compound 31 with
fuming nitric acid gave compound 32, which was then reduced with
tin dichloride to afford compound 33 in nearly quantitative yield.
The conversion of aniline 33 into phenol 30 proved to be prob-
lematic. The stepwise conversion, treating compound 33 first with
sodium nitrite in sulfuric acid and then with aqueous NaOH gave
only trace amounts of the desired product. The Bucherer reaction
with sodium hydrogensulfite,16 a direct conversion from aniline
to phenol, failed to give the desired result. We reasoned that so-
dium hydrogensulfite might not be sufficiently acidic for the quin-
oline substrate and therefore heated compound 33 at 210 °C for 2 h
in a microwave reactor in the presence of phosphoric acid resulting
in complete transformation of compound 33 to 5-hydroxyquino-
line 30.
5N HCl
38%
Cl
26
Cl
27
1) NaOMe, µwave,
140 °C;
HBr, AcOH, 41%
2) Pd/C, H2,
82%
X
N
R
28 X = Cl, R = OMe
25 X = Cl, R = OH
29
X = H, R = OH
Scheme 5. Synthesis of compound 25.
In summary, a series of 5-hydroxyquinolines has been prepared.
Several regioisomers were made either by selective displacement
of a leaving group or by using a bromo substituent as a blocking
group in the Skraup reaction. The bromo group was found to be
an excellent blocking group due to its stability during the Skraup
conditions and easy removal thereafter. Halides at the 5-position
of quinoline were found to be much more reactive than those at
the 7- and 8-positions. Finally, we have also found a unique meth-
od to reduce the pyridyl ring on quinolines, leaving a halogen sub-
stituent untouched.
Compound 22 underwent Skraup cyclization to provide the desired
compound 23, without evidence of debromination. Heating meth-
oxyquinoline 23 in HBr/AcOH afforded the expected compound 24,
with trace amounts of compound 16 also observed.
Although it has been reported that bromo groups para or ortho
to an amino group are readily removed with HBr/AcOH,14 extended
heating time did not further promote debromination of 24. We
hypothesized that the addition of a reagent to scavenge any Br2
produced might further promote the debromination reaction. In
the presence of aniline (3 equiv) as bromine-scavenger, compound
23 was completely transformed to the desired compound 16 after
heating at 120 °C with HBr/AcOH overnight. Upon cooling to room
temperature, the solid was removed by filtration and the filtrate
was then treated with saturated aqueous Na2CO3 solution to give
a brown precipitate. Rinsing the isolated precipitate with ether fol-
lowed by drying gave compound 16, as determined by 1H NMR.
The planned synthesis of 7-chloro derivative 25 was based on
the belief that regioselective chloride displacement from 27 could
be achieved (Scheme 5).12 Compound 27 was readily prepared by
the Skraup reaction. Treatment of compound 27 with NaOMe at
140 °C in a microwave reactor for 4 h afforded an inseparable mix-
ture of compounds 28 and 25. Pure compound 25 was isolated
after demethylation with HBr/AcOH. Unfortunately 1H NMR analy-
sis could not exclude the possibility that 5-chloro-7-hydroxyquin-
oline had been formed rather than the desired compound 25.
Confirmation of the desired and expected regioselectivity was
achieved by hydrogenolysis to produce the known compound 29.
Synthesis of 3-chloro derivative 30 using the Skraup reaction
would require the starting material 2-chloroacrolein. The literature
preparation of 2-chloroacrolein reports the reaction of acrolein with
References and notes
1. (a) Chauhan, P. M.; Srivastava, S. K.. Curr. Med. Chem. 2001, 8, 1535; (b) Mihaly,
G. W.; Ward, S. A.; Edwards, G. Br. J. Clin. Pharmacol. 1985, 19, 745; (c) Sadeque,
A. J.; Wandel, C.; He, H.; Shah, S.; Wood, A. J. Clin. Pharmacol. Ther. 2000, 68,
231; (d) Sweeney, T. R. Med. Res. Rev. 1981, 1, 281.
2. (a) Kirsch, R.; Kleim, J.; Riess, G.; Rosenstock, B.; Rösner, M.; Winkler, I. PCT Int.
Appl. WO1997037977, 1997.; (b) Azuma, R.; Saeki, M.; Yamamoto, Y.;
Hagiwara, Y.; Grochow, L. B.; Donehower, R. C. Xenobiotica 2002, 63; (c)
Baker, W. R.; Ryckman, D. M.; Cai, S.; Dimitroff, M.; Shang, X. PCT Int. Appl.
WO2002018345, 2002.; (d) Jaroch, S.; Lehmann, M.; Schmees, N.; Berger, M.;
Rehwinkel, H.; Krolikiewicz, K.; Skuballa, W.; Schäcke, H.; Schottelius, A. PCT
Int. Appl. WO2003082827, 2003.
3. (a) Combes, A. Bull. Soc. Chim. Fr. 1888, 49, 89; (b) Yamashkin, S. A.; Yudin, L. G.;
Kost, A. N. Chem. Heterocycl. Compd. 1993, 845; (c) Sanna, P.; Carta, A.; Paglietti,
G. Heterocycles 1999, 51, 2171.
4. (a) Conrad, M.; Limpach, L. Ber. Dtsch. Chem. Ges. 1887, 20, 944; (b) Jaroszewski,
J. W. J. Heterocycl. Chem. 1990, 27, 1227; (c) Wang, H.-K.; Bastow, K. F.;
Cosentino, L. M.; Lee, K.-H. J. Med. Chem. 1996, 39, 1975; (d) Raban, M.; Martin,
V. A.; Craine, L. J. Org. Chem. 1990, 55, 4311.
5. (a) Friedlander, P. Ber. Dtsch. Chem. Ges. 1882, 15, 2572; (b) Cheng, C.-C.; Yan, S.-
J. Org. React. 1982, 28, 37; (c) Thummel, R. P. Synlett 1992, 1; (d) McNaughton, B.
R.; Miller, B. L. Org. Lett. 2003, 5, 4257; (e) Arcadi, A.; Chiarini, M.; Giuseppe, S.
D.; Marinelli, F. Synlett 2003, 203; (f) Yadav, J. S.; Reddy, B. V. S.; Premalatha, K.
Synlett 2004, 963.
6. (a) Gould, R. G.; Jacobs, W. A. J. Am. Chem. Soc. 1939, 61, 2890; (b) Dave, C. G.;
Shah, R. D. Heterocycles 1999, 51, 1819; (c) Zhang, M. Q.; Haemers, A.; Berghe, V.
D.; Pattyn, S. R.; Bollaert, W.; Levshin, I. J. Heterocycl. Chem. 1991, 28, 673.
7. (a) Meth-Cohn, O. Heterocycles 1993, 35, 539; (b) Toyota, M.; Komori, C.; Ihara,
M. J. Org. Chem. 2000, 65, 7110; (c) Hayes, R.; Meth-Cohn, O. Tetrahedron Lett.
1982, 23, 1613.
8. (a) Bergstrom, F. W. Chem. Rev. 1944, 35, 77; (b) Deady, L. W.; Kaye, A. J.; Finlay,
G. J.; Baguley, B. C.; Denny, W. A. J. Med. Chem. 1997, 40, 2040.
9. (a) Skraup, Z. H. Ber. 1880, 13, 2086; (b) O’Neill, P. M.; Tingle, M. D.; Mahmud,
R.; Storr, R. C.; Ward, S. A.; Park, B. K. Bioorg. Med. Chem. Lett. 1995, 5, 2309; (c)
Fujiwara, H.; Kitagawa, K. Heterocycles 2000, 53, 409; (d) Boger, D. L.; Boyce, C.
W. J. Org. Chem. 2000, 65, 4088.
1) HNO3,
88%
N
N
Cl
Cl
2) SnCl2
R
32
MeOH, reflux
31
99%
R = NO2
33 R = NH2
10. (a) Li, J. Named Reactions in Heterocyclic Chemistry; John Wiley
Hoboken, 2005. p. 488; (b) Eva, R. R. U.S. Patent 6103904, 2000.
11. Leir, C. M. J. Org. Chem. 1977, 42, 911.
& Sons:
H3PO4,
210 °C
quant.
12. (a) Johnson, C. N.; Rami, H. K.; Stemp, G.; Thewlis, K.; Thompson, M.; Vong,
A.K.K. PCT Int. Appl. WO 2002034754, 2002.; (b) Ward, S. E. PCT Int. Appl. WO
2003068771, 2003.
13. Fukata, G.; Kubota, Y.; Mataka, S.; Thiemann, T.; Tashiro, M. Bull. Chem. Soc. Jpn.
1994, 67, 592.
14. Choi, H. Y.; Chi, D. Y. J. Am. Chem. Soc. 2001, 123, 9202.
15. Guest, H.R.; Stansbury, H.A., Jr. U.S. Patent 2815385, 1957.
16. (a) Sauer, E.; Polz, K.; Schopf, G.; Bendig, J. J. Prakt. Chem. 1991, 333, 467; (b)
Seeboth, H. Angew. Chem., Int. Ed. Engl. 1967, 6, 307; (c) Gilbert, E. E. Sulfonation
and Related Reactions; John Wiley & Sons: New York, 1965. p 166.
N
Cl
OH
30
Scheme 6. Synthesis of compound 30 via the Bucherer reaction.